Ralf Dikow, Marcin Adamczak, Daniel Ernesto Henriquez, Eberhard Ritz

Slides:



Advertisements
Similar presentations
Renal disease and hypertension in non–insulin-dependent diabetes mellitus Nuhad Ismail, Bryan Becker, Piotr Strzelczyk, Eberhard Ritz Kidney International.
Advertisements

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Stephen P. McDonald, Graeme R. Russ  Kidney International 
LDL cholesterol in CKD—to treat or not to treat?
Beta blockers in the management of chronic kidney disease
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Kidney transplantation in a low-resource setting: Nigeria experience
Volume 61, Issue 2, Pages (February 2002)
Progression of renal failure and hypertensive nephrosclerosis
Burden of chronic kidney disease: North Africa
Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2  Robert N. Foley, Charles A. Herzog, Allan.
Haiyan Wang, Luxia Zhang, Jicheng Lv  Kidney International 
Francesco Paolo Schena  Kidney International 
Need for better diabetes treatment for improved renal outcome
Volume 70, Pages S21-S25 (December 2006)
Left ventricular hypertrophy in renal failure
George A. Kaysen, Burl R. Don
Ian H. de Boer, Rajnish Mehrotra  Kidney International 
Comorbidity and confounding in end-stage renal disease
Volume 70, Issue 11, Pages (December 2006)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
The epidemiology of chronic kidney disease
Calcification and cardiovascular problems in renal failure
Edmund G. Lowrie  Kidney International 
Study of Heart and Renal Protection (SHARP)
Pieter Evenepoel, Björn K. Meijers  Kidney International 
LDL cholesterol in CKD—to treat or not to treat?
Acute myocardial infarction in patients with end-stage renal disease
Volume 71, Issue 6, Pages (March 2007)
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
Response to ‘Hepcidin levels in patients with renal disease’
Endothelial dysfunction and inflammation: What is the link?
New insights in uremic toxins
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Elevated risk of stroke among patients with end-stage renal disease
Nephrology in Latin America, with special emphasis on Brazil
Cardiovascular disease in pediatric chronic dialysis patients
Volume 79, Issue 9, Pages (May 2011)
AGEs in foods: Do they play a role in uremia?
Non–high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease  Yoshiki Nishizawa,
Volume 87, Issue 1, Pages (January 2015)
Counteracting progression of renal disease: A look into the future
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson  Kidney International 
Volume 62, Issue 3, Pages (September 2002)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 73, Issue 9, Pages (May 2008)
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Phosphate binders on iron basis: A new perspective?
Volume 72, Issue 2, Pages (July 2007)
Volume 55, Pages S3-S16 (June 1999)
The Danish Renal Biopsy Register
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Volume 62, Pages S68-S72 (December 2002)
Volume 70, Issue 5, Pages (September 2006)
Volume 75, Issue 7, Pages (April 2009)
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Volume 70, Issue 10, Pages (November 2006)
Volume 63, Issue 5, Pages (May 2003)
Kidney and hypertension
Morphology of the heart and arteries in renal failure
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Ralf Dikow, Marcin Adamczak, Daniel Ernesto Henriquez, Eberhard Ritz Strategies to decrease cardiovascular mortality in patients with end-stage renal disease  Ralf Dikow, Marcin Adamczak, Daniel Ernesto Henriquez, Eberhard Ritz  Kidney International  Volume 61, Pages S5-S10 (May 2002) DOI: 10.1046/j.1523-1755.61.s80.3.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Comparison of insulin-dependent glucose uptake in the isolated prefused heart of rats with uremia,P < 0.01. (after reference[23]). Kidney International 2002 61, S5-S10DOI: (10.1046/j.1523-1755.61.s80.3.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Reduced renal cortical norepinephrine content as an index of sympathetic nerve density (A) in the present increased stimulation-induced release of 3-H-Norepinephrine from prelabeled tissue and nerve fibers as an index of greater activity of the renal sympathetic nerve system (B). Symbols are: control (open box); SNX (shaded box). (after[57]). Kidney International 2002 61, S5-S10DOI: (10.1046/j.1523-1755.61.s80.3.x) Copyright © 2002 International Society of Nephrology Terms and Conditions